Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies

TERMINATED

Identifier: CI-TRIAL-00080061
Entity page: /trial/NCT01998035 ↗
Edges: 8

Neighbours: 3 cancers2 drugs
Drawn: 5 of 5 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies condition of …CONDITION_OFderived3 of 3
← condition of	Hodgkin Lymphoma registry condition “Hodgkin Lymphoma” mapped ONTOLOGY_EXACT	—	—	Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
← condition of	Lymphoma registry condition “Lymphoma” mapped ONTOLOGY_EXACT	—	—

Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies intervention of …INTERVENTION_OFderived5 of 5
← intervention of	Azacitidinesmall molecule registry intervention “Oral 5-Azacitidine 100 MG” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Azacitidinesmall molecule registry intervention “Oral 5-Azacitidine 200 MG” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Azacitidinesmall molecule registry intervention “Oral 5-Azacitidine 300 MG” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Romidepsinother registry intervention “RomiDEPsin 10 MG/M2” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Romidepsinother registry intervention “Romidepsin 14 MG/M2” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies intervention of …INTERVENTION_OFderived5 of 5

← intervention of

Azacitidinesmall molecule

registry intervention “Oral 5-Azacitidine 100 MG” (DRUG) mapped ALIAS

—

not mapped

Observed

clinicaltrials

graph →

← intervention of

Azacitidinesmall molecule

registry intervention “Oral 5-Azacitidine 200 MG” (DRUG) mapped ALIAS